Earnings Recaps

Browse reported earnings of the most popular stocks

Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026 Jan 7, 2026 Jan 6, 2026 Dec 19, 2025 Dec 18, 2025 Dec 17, 2025 Dec 12, 2025 Dec 11, 2025 Dec 10, 2025 Dec 9, 2025 Dec 6, 2025 Dec 5, 2025 Dec 4, 2025 Dec 3, 2025 Dec 2, 2025 Dec 1, 2025 Nov 27, 2025 Nov 26, 2025 Nov 25, 2025 Nov 24, 2025 Nov 23, 2025 Nov 21, 2025 Nov 20, 2025 Nov 19, 2025 Nov 18, 2025 Nov 17, 2025 Nov 15, 2025 Nov 14, 2025 Nov 13, 2025 Nov 12, 2025 Nov 11, 2025 Nov 10, 2025 Nov 9, 2025 Nov 8, 2025 Nov 7, 2025 Nov 6, 2025 Nov 5, 2025 Nov 4, 2025 Nov 1, 2025 Oct 31, 2025 Oct 30, 2025 Oct 29, 2025 Oct 28, 2025 Oct 27, 2025 Oct 25, 2025 Oct 24, 2025 Oct 23, 2025 Oct 22, 2025 Oct 21, 2025 Oct 17, 2025 Oct 16, 2025 Oct 15, 2025 Oct 14, 2025 Oct 9, 2025 Oct 8, 2025 Oct 7, 2025 Sep 25, 2025 Sep 23, 2025 Sep 17, 2025 Sep 16, 2025 Sep 11, 2025 Sep 10, 2025 Sep 9, 2025 Sep 5, 2025 Sep 4, 2025 Sep 3, 2025 Sep 2, 2025 Sep 1, 2025 Aug 28, 2025 Aug 26, 2025 Aug 25, 2025 Aug 22, 2025 Aug 21, 2025 Aug 20, 2025 Aug 19, 2025 Aug 18, 2025 Aug 15, 2025 Aug 14, 2025 Aug 13, 2025 Aug 12, 2025 Aug 11, 2025 Aug 9, 2025 Aug 8, 2025 Aug 2, 2025 Aug 1, 2025 Jul 30, 2025 Jul 29, 2025 Jul 25, 2025
11 companies Today

Tencent Holdings Limited

0700.HK Q2 2025
Reported: 2025-08-15

Tencent Holdings demonstrated robust growth in Q2 2025, with total revenue rising 15% year-on-year to RMB 185 billion, driven by its successful gaming and advertising segments, alongside significant AI investments.

Key takeaways
  • Non-IFRS operating profit climbed 18% year-on-year to RMB 69 billion, reflecting strong operational efficiency amidst ongoing AI integration.
  • Value-added services (VAS) represented 50% of total revenue, with domestic games revenue increasing by 17% year-on-year, bolstered by new titles and established favorites.
  • Marketing services revenue surged 24% year-on-year, benefiting from an upgraded advertising foundation model.
  • Combined monthly active users (MAUs) for Weixin and WeChat reached 1.4 billion, underpinning the strength of Tencent’s ecosystem.
  • AI applications are increasingly embedded across products, enhancing user engagement and service delivery.

Applied Materials, Inc.

AMAT Q3 2025
Reported: 2025-08-15

Applied Materials reported record performance in Q3 FY2025, driven by strong demand for semiconductor systems, though it anticipates a slight revenue decline in Q4 due to uncertainties in the China market.

Key takeaways
  • Revenue from the metal deposition business reached nearly $1.2 billion, reflecting robust performance in leading-edge foundries.
  • The etch business surged past $1 billion in quarterly revenue for the first time, driven by strong demand from DRAM customers.
  • Applied is investing over $200 million in Arizona to enhance U.S. manufacturing capacity, reinforcing its commitment to the American semiconductor supply chain.
  • The company expects continued market share gains in leading-edge foundry, DRAM, and advanced packaging segments as new technologies ramp up production.
  • Overall, Applied is positioned for mid-single-digit revenue growth in FY2025, marking the sixth consecutive year of growth, despite near-term headwinds.

Bionano Genomics, Inc.

BNGO Q2 2025
Reported: 2025-08-15

Bionano's Q2 2025 results reflect strategic progress with a 5% adjusted revenue decline despite a robust 17% year-over-year increase in flowcell sales, driven by routine user engagement.

Key takeaways
  • Total revenue for Q2 2025 was $6.7 million, a 13% decline from Q2 2024, but a 5% decrease when excluding discontinued services.
  • Flowcell sales surged 17% year-over-year, indicating strong demand within the routine user base.
  • Non-GAAP gross margin improved significantly to 52%, up from 35% in the same quarter last year.
  • Operating expenses were reduced by 53% year-over-year, totaling $8.8 million in Q2 2025.
  • The installed base of optical genome mapping systems remains stable at 378, with 16 new systems installed in the first half of 2025.

Community

See what investors are trading, holding, and sharing

🌐
All
📈
Stock
📊
ETF
🏦
Mutual Fund
🪙
Crypto
💱
Forex
# Asset Price Community % Type Currency Sector
Loading...